Using synthetic biology and AI to address global antimicrobial resistance threat
Driven by overuse and misuse of antibiotics, drug-resistant infections are on the rise, while development of new antibacterial tools has slowed.
Antibiotics
3 Questions: Using AI to accelerate the discovery and design of therapeutic drugs
Professor James Collins discusses how collaboration has been central to his research into combining computational predictions with new experimental platforms.
Read MoreAI maps how a new antibiotic targets gut bacteria
MIT CSAIL and McMaster researchers used a generative AI model to reveal how a narrow-spectrum antibiotic attacks disease-causing bacteria, speeding up a process that normally takes years.
Read MoreUsing generative AI, researchers design compounds that can kill drug-resistant bacteria
The team used two different AI approaches to design novel antibiotics, including one that showed promise against MRSA.
Read More
You must be logged in to post a comment.